Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice.

Authors: Deol, Poonamjot; Fahrmann, Johannes; Yang, Jun; Evans, Jane R; Rizo, Antonia; Grapov, Dmitry; Salemi, Michelle; Wanichthanarak, Kwanjeera; Fiehn, Oliver; Phinney, Brett; Hammock, Bruce D; Sladek, Frances M

Published In Sci Rep, (2017 Oct 02)

Abstract: Soybean oil consumption is increasing worldwide and parallels a rise in obesity. Rich in unsaturated fats, especially linoleic acid, soybean oil is assumed to be healthy, and yet it induces obesity, diabetes, insulin resistance, and fatty liver in mice. Here, we show that the genetically modified soybean oil Plenish, which came on the U.S. market in 2014 and is low in linoleic acid, induces less obesity than conventional soybean oil in C57BL/6 male mice. Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils, coconut oil, and a low-fat diet. Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 (ω6) and omega-3 (ω3) fatty acids (linoleic and α-linolenic acid, respectively) in the cytochrome P450/soluble epoxide hydrolase pathway. While Plenish induced less insulin resistance than conventional soybean oil, it resulted in hepatomegaly and liver dysfunction as did olive oil, which has a similar fatty acid composition. These results implicate a new class of compounds in diet-induced obesity-C18 epoxide and diol oxylipins.

PubMed ID: 28970503 Exiting the NIEHS site

MeSH Terms: Animals; Coconut Oil/administration & dosage; Cytochrome P-450 Enzyme System/genetics; Cytochrome P-450 Enzyme System/metabolism; Diet, Fat-Restricted/methods; Dietary Fats/adverse effects; Fatty Acids, Omega-3/classification; Fatty Acids, Omega-3/metabolism*; Fatty Acids, Omega-6/classification; Fatty Acids, Omega-6/metabolism*; Gene Expression Profiling; Hepatomegaly/etiology*; Hepatomegaly/genetics; Hepatomegaly/metabolism; Hepatomegaly/pathology; Insulin Resistance; Lipid Metabolism/drug effects; Lipid Metabolism/genetics; Liver/drug effects; Liver/metabolism; Male; Metabolome/genetics; Mice; Mice, Inbred C57BL; Obesity/etiology*; Obesity/genetics; Obesity/metabolism; Obesity/pathology; Oxylipins/classification; Oxylipins/metabolism*; Proteome/genetics; Proteome/metabolism; Soybean Oil/adverse effects*

Back
to Top